Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion type Assertion NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_head.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion description "[However, this subset of lung cancers has received renewed attention due to the introduction of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitors showing the dramatic therapeutic response on selected patients with activating EGFR mutations which occur more commonly in never smokers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_provenance.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion evidence source_evidence_literature NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_provenance.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion SIO_000772 21272954 NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_provenance.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion wasDerivedFrom befree-20140225 NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_provenance.
- NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_assertion wasGeneratedBy ECO_0000203 NP480230.RAP9Hw2_Vtf7nAJZQUMKvIDZnrogP5eImoiY_sFiAaxOQ130_provenance.